Medical Devices
-
Boston Scientific names Joseph Fitzgerald as chief operating officer
Fitzgerald will oversee three newly established reportable segments as Boston Scientific works to bounce back from guidance cuts.
By Nick Paul Taylor • Oct. 8, 2026 -
Medtronic names Felicia Kurz as cardiac ablation VP, GM
Kurz’s appointment comes as Medtronic enjoys strong growth in electrophysiology therapies thanks to demand for its pulsed field ablation devices.
By Susan Kelly • Oct. 7, 2026 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Abbott gets FDA nod for updates to heart failure monitoring system
Patients can view their pulmonary artery pressure readings on their phone with the CardioMEMS updates, giving them a more active role in their care.
By Elise Reuter • Oct. 7, 2026 -
Apple ordered to pay Masimo $184M in interest on patent damages
A U.S. district court ruled that Apple owes prejudgment interest on the $634 million in damages it incurred for infringing Masimo’s pulse oximetry patent.
By Nick Paul Taylor • Oct. 7, 2026 -
Zenflow raises $52M, inks distribution deal with Cook Medical
Cook Medical has become Zenflow’s U.S. distributor in a urology device market targeted by Boston Scientific, Olympus and Teleflex.
By Nick Paul Taylor • Oct. 6, 2026 -
Stryker CEO Kevin Lobo to resign
Lobo will step down on Dec. 31 as CEO after more than 15 years at Stryker. Chief operating officer Spencer Stiles will lead the company.
By Elise Reuter • Oct. 6, 2026 -
BD strikes supply chain pact with Trump administration
BD plans to increase U.S. production of essential medical consumables in exchange for relief from future tariffs on its products.
By Susan Kelly • Oct. 6, 2026 -
Top medtech conferences in 2027
From AdvaMed’s meeting in San Francisco to a robotics conference in Rome, next year’s calendar is already filled with medtech events to attend.
By Ricky Zipp • Oct. 6, 2026 -
GE HealthCare to acquire Sofie Biosciences for $945M
Sofie Biosciences is expected to expand GE HealthCare’s footprint in the radiopharmaceutical industry, helping manufacture and distribute time-sensitive drugs used in PET imaging.
By Susan Kelly • Oct. 5, 2026 -
Q&A
After years-long turnaround, Convatec’s new CEO plans R&D push
Jonny Mason, who became CEO of the medtech firm a year ago following the death of Karim Bitar, said Convatec’s pace of launching new devices has accelerated for 2026 and 2027.
By Elise Reuter • Oct. 5, 2026 -
ARPA-H awards more than $100M to biosensor development projects
Four organizations will develop devices for tracking heart disease, inflammation and perimenopause.
By Nick Paul Taylor • Oct. 5, 2026 -
Retrieved from Michigan Medicine on October 02, 2026
Edwards’ adjustable heart valve for children lands FDA approval
The device could help young patients avoid multiple open-heart surgeries as they grow, FDA officials said.
By Susan Kelly • Oct. 2, 2026 -
FDA to prioritize guidance on AI, surgical robots next year
The FDA outlined its A-list and B-list guidance priorities for the 2027 fiscal year.
By Nick Paul Taylor • Oct. 2, 2026 -
FDA selects first 5 participants for READI-Home initiative
The innovation challenge is focused on developing home devices that could help reduce hospital readmissions.
By Elise Reuter • Oct. 1, 2026 -
Medtronic drug-coated balloon gets FDA breakthrough status
Medtronic plans to study the device in patients with peripheral artery disease below the knee, a historically difficult condition to treat.
By Susan Kelly • Oct. 1, 2026 -
Medtronic reveals cardiac mapping and ablation software clearances
The regulatory authorizations come as Medtronic looks to differentiate itself in the fast-growing pulsed field ablation market targeted by rivals Abbott, Boston Scientific and J&J.
By Nick Paul Taylor • Oct. 1, 2026 -
US-China trade board carves path for tariff relief on $60B of goods
The board has proposed lower tariffs on U.S.-bound household goods and toys, but the White House did not specify reduction amounts or an implementation date.
By Max Garland • Sept. 30, 2026 -
Sofinnova raises 82M euros to fund medtech startups
The venture capital firm expects to launch up to eight new medtech ventures over the next five years.
By Susan Kelly • Sept. 29, 2026 -
Carlsmed names new CFO
Former ZimVie CFO Richard Heppenstall fills the vacancy created by the departure of Leo Greenstein, who is leaving Carlsmed to pursue other professional interests.
By Nick Paul Taylor • Sept. 29, 2026 -
FDA issues draft guidance for surgical robots
A two-day public workshop on evaluating robotic surgery systems with autonomous or remote capabilities is also on the agency’s agenda, as telesurgery advances globally.
By Susan Kelly • Sept. 28, 2026 -
GE HealthCare to explore applying generative AI to radiation therapy workflows
The company has teamed up with a Mass General Brigham research team to help care teams access patient-specific information.
By Nick Paul Taylor • Sept. 28, 2026 -
Intuitive expands push into cardiac market with CE mark
After de-emphasizing heart surgery for decades due to limits with its earlier platforms, the surgical robot maker is eyeing the large market in cardiovascular disease treatment.
By Susan Kelly • Sept. 25, 2026 -
Precision Neuroscience raises $250M for brain-computer interface work
The Series D round is part of a surge in investment into BCI startups and brings Precision Neuroscience’s total funding to $430 million.
By Nick Paul Taylor • Sept. 25, 2026 -
BD hires Arthur Hu as chief information and digital officer
BD predicted that Hu’s experience at Lenovo will be an important advantage as technology becomes increasingly central to how leading medtech companies operate.
By Nick Paul Taylor • Sept. 24, 2026 -
CVRx names John Landry as CFO
Landry joins in the aftermath of an investor’s call for the sale of the heart failure device company.
By Nick Paul Taylor • Sept. 23, 2026